Finance

Mga Listahan
GEHC:NASDAQ
GE HealthCare Technologies Inc
$71.72
-1.04%
(-0.76) 1D
Ago 28, 4:00:01 PM GMT-4  ·   USD
Lahat ng simbolo
SimboloPresyoPalitan% ng Pagbabago
Bumubuo ng mga nangungunang insight para sa GEHC...
Buksan
$72.82
Mataas
$73.00
Mababa
$71.57
Mkt. cap
32.40B
Avg. na dami
4.24M
Dami
328.00
Dividend
0.20%
Bawat tatlong buwang dividend
$0.04
Petsa ng ex-dividend
Hul 24, 2026
P/E ratio
16.49
Mataas nang 52-wk
$89.77
Mababa nang 52-wk
$58.75
EPS
$4.35
Beta
0.82
Mga natitirang share
451.69M
Bilang ng mga empleyado
54K
Buksan
$72.82
Mataas
$73.00
Mababa
$71.57
Mkt. cap
32.40B
Avg. na dami
4.24M
Dami
328.00
Dividend
0.20%
Bawat tatlong buwang dividend
$0.04
Petsa ng ex-dividend
Hul 24, 2026
P/E ratio
16.49
Mataas nang 52-wk
$89.77
Mababa nang 52-wk
$58.75
EPS
$4.35
Beta
0.82
Mga natitirang share
451.69M
Bilang ng mga empleyado
54K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Profile
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures contrast agents and radiopharmaceuticals. GE HealthCare's primary customers are hospitals and health networks. In 2023, the company received 42% of its revenue in the United States and 13% of its revenue from China, where the company faces increasing competition. GE HealthCare was originally the healthcare division of the American conglomerate General Electric, which spun it off in 2023 as an independent, publicly traded company. It operates in more than 100 countries, with GE HealthCare major regional operations in Buc, France; Helsinki, Finland; Kraków, Poland; Budapest, Hungary; Yizhuang, China; Hino & Tokyo, Japan, and Bangalore, India. Wikipedia
Tungkol sa GE HealthCare Technologies Inc
CEOPeter J Arduini
Mga Empleyado54K
Itinatag1994
HeadquartersChicago, Illinois, Estados Unidos
Sektor-
Mga rating ng analyst
Batay sa 14 (na) analyst na nagbigay ng mga rating ng stock sa GEHC sa nakalipas na 3 buwan
Pagbili
Pagbili
9
Pag-hold
5
Pagbebenta
0
12 buwang forecas
Batay sa 14 (na) analyst sa Wall Street na nag-aalok ng mga target na presyo sa loob ng 12 buwan para sa GEHC sa nakalipas na 3 buwan.
Pinakamataas
Kasalukuyan $71.72
$92.00 (+28.27%)
Average
$79.07 (+10.24%)
Pinakamababa
$70.00 (-2.41%)
Analyst
Rekomendasyon
Aksyon
Target na presyo
Inaasahan
Petsa
Larry Biegelsen
Wells Fargo
Buy
Reiterated
$85.00
+18.5%
08/25/2026
Ryan Zimmerman
BTIG
Buy
Maintained
$79.00
+10.1%
08/19/2026
Joanne Wuensch
Citi
Hold
Maintained
$75.00
+4.6%
08/13/2026
Travis Steed
Bank of America Securities
Hold
Maintained
$74.00
+3.2%
08/11/2026
Graham Doyle
UBS
Hold
Reiterated
$73.00
+1.8%
07/31/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
$85.00
+18.5%
07/31/2026
Robbie Marcus
J.P. Morgan
Hold
Reiterated
$70.00
-2.4%
07/30/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
$80.00
+11.5%
07/30/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
$84.00
+17.1%
07/30/2026
Suraj Kalia
Oppenheimer
Buy
Maintained
$85.00
+18.5%
07/30/2026
Matthew Taylor
Jefferies
Buy
Reiterated
$92.00
+28.3%
07/30/2026
Vik Chopra
BMO Capital
Hold
Maintained
$71.00
-1%
07/30/2026
Kendall Au
RBC Capital
Buy
Reiterated
$80.00
+11.5%
07/29/2026
Shagun Singh Chadha
RBC Capital
Buy
Reiterated
$80.00
+11.5%
07/29/2026
Jason Bednar
Piper Sandler
Buy
Reiterated
$74.00
+3.2%
07/24/2026
Unknown Analyst
BMO Capital
Hold
Initiated
$70.00
-2.4%
07/09/2026
David Roman
Goldman Sachs
Hold
Downgraded
-
-
04/30/2026
Matt Miksic
Barclays
Hold
Maintained
$78.00
+8.7%
04/30/2026
David Toung
Argus Research
Buy
Reiterated
$95.00
+32.5%
03/03/2026
Patrick Wood
Morgan Stanley
Hold
Maintained
$85.00
+18.5%
02/05/2026
Nico Chen
DBS
Buy
Maintained
$100.00
+39.4%
01/28/2026
Huling ulat
Hul 29, 2026
Fiscal period
Q2 2026
EPS / Pagtataya (USD)
$1.13 / $1.04
+9.09%lumampas
Kita / Pagtataya (USD)
5.30B / 5.26B
+0.69%lumampas
Earnings call para sa Fiscal Q2 2026
Hinihintay ang earnings call
Sa isang sulyap
Mga insight mula sa mga pinakabagong balita at ulat
Mga nakaraang ulatLahat ng value sa USD
Loading Previous Earnings...
Statement ng kita
Kita
Net na kita
Lahat ng value sa USD
Set 2025
Dis 2025
Mar 2026
Hun 2026
Kita
5.14B
5.70B
5.13B
5.30B
Gastusin sa mga naibentang produkto
3.15B
3.44B
3.15B
3.12B
Halaga ng kita
3.15B
3.44B
3.15B
3.12B
Mga gastos sa pananaliksik at pag-develop
292.00M
323.00M
345.00M
323.00M
Kabuuang gastos sa pananaliksik at pag-develop
-
-
-
-
Mga gastos sa pagbebenta, pangkalahatan, at admin
966.00M
1.04B
1.06B
1.06B
Gastos sa pagpapatakbo
1.26B
1.36B
1.41B
1.39B
Kabuuang gastos sa pagpapatakbo
4.41B
4.80B
4.56B
4.50B
Kita sa pagpapatakbo
731.00M
896.00M
569.00M
793.00M
Iba pang hindi kita sa pagpapatakbo
11.00M
4.00M
36.00M
7.00M
EBT na may mga hindi karaniwang item
643.00M
821.00M
505.00M
693.00M
EBT na hindi kasama ang mga hindi karaniwang item
643.00M
821.00M
505.00M
693.00M
Gastos sa buwis sa kita
179.00M
219.00M
94.00M
119.00M
Epektibong rate ng buwis
27.84%
26.67%
18.61%
17.17%
Iba pang gastos sa pagpapatakbo
-
-
-
-
Net na kita
446.00M
589.00M
389.00M
561.00M
Margin ng kabuuang kita
8.67%
10.34%
7.58%
10.59%
Kita bawat share
1.07
1.44
0.99
1.13
Kita sa interes at investment
12.00M
24.00M
-
7.00M
Gastos sa interes
-128.00M
-6.00M
-115.00M
-133.00M
Mga net na gastos sa interes
-116.00M
18.00M
-115.00M
-126.00M
Mga singil sa depreciation at amortization
-
-
-
-
EBITDA
879.00M
1.04B
722.00M
953.00M
Kita o pagkalugi mula sa pagbebenta ng mga asset
-
-
-
-
Mga transaksyon ng insider
Kinukuha ang data ng mga insider na transaksyon mula sa mga third-party na source. Matuto pa
Insider
Posisyon
Uri
Petsa
Mga Share
Halaga
Page 1
Posibleng magkaroon ng mga pagkakamali ang AI content. Matuto pa
Posibleng magkaroon ng mga pagkakamali ang AI content. Matuto pa
Mga app ng Google